Gary Lee, Ph.D.

Gary Lee, Ph.D.

Chief Scientific OfficeratLyell Immunopharma· In proxies 2021–2025

Pay in FY2025+48% from the year before · Lyell Immunopharma stock +140.5% the same year

Gary Lee, Ph.D. was paid $1.9M in FY2025 (Dec), up 48%. Lyell Immunopharma stock rose 140.5% that year.

Pay$100 in the stock at the end of FY21 → $20
Pay is from the Summary Compensation Table of each Lyell Immunopharma proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Lyell ImmunopharmaPublic company · 5 yr
    • Chief Scientific Officer2021 – Present · 5 yrStock in role -97%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?